o-Toluoyl Chloride CAS 933-88-0 Tolvaptan Intermediate Factory High Quality
Ubonelelo loMvelisi, uMgangatho oPhezulu, iMveliso yoRhwebo
I-Tolvaptan kunye nabaPhakathi abaNxulumeneyo:
Tolvaptan CAS 150683-30-0
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-enye CAS 160129-45-3
o-Toluoyl Chloride CAS 933-88-0
I-4-Amino-2-Methylbenzoic Acid CAS 2486-75-1
I-2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5
Igama leMchiza | o-Toluoyl Chloride |
Izithethantonye | 2-Methylbenzoyl Chloride |
Inombolo yeCAS | 933-88-0 |
Inombolo yeCAT | RF-PI396 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C8H7ClO |
Ubunzima beMolekyuli | 154.59 |
Indawo yokunyibilika | 159.5-160.9℃ |
Indawo yokubilisa | 88.0~90.0℃/12 mmHg (lit.) |
Ukuxinana | 1.185 g/mL ku-25℃ (lit.) |
Refractive Index | n20/D 1.5549(lit.) |
Ukunyibilika kwamanzi | Iyasabelana naManzi |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Ulwelo olucacileyo olungenambala |
Isivavanyi | ≥99.0% |
Benzoyl Chloride | ≤0.30% |
M&P-Methyl Benzoyl Chloride | ≤0.50% |
I-O-Toluic Acid | ≤0.50% |
Okunye Ukungcola Okungachazwanga | ≤0.20% |
Ukungcola ngokupheleleyo | ≤1.0% |
Ilahleko ekomisweni | ≤0.50% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, 25kg / umphanda okanye 180kg igubu Plastic, okanye ngokwemfuno umthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-o-Toluoyl Chloride (i-CAS 933-88-0) isetyenziswe njengendawo ephakathi kweyeza.I-o-Toluoyl Chloride isetyenziswa kwi-synthesis ukuba i-quinolinone idibanisa njenge-SARS CoV 3CLpro inhibitors.Kwakhona isetyenziswe kwi-synthesis ye-benzooxaboroles njenge-agent echasene nokuvuvukala ngomlomo.I-o-Toluoyl Chloride iphakathi kweTolvaptan (CAS 150683-30-0) yonyango lwe-hyponatremia.I-Tolvaptan, eyaziwa nangokuthi i-OPC-41061, i-arginine i-vasopressin receptor 2 antagonist ekhethiweyo, ekhuphisanayo esetyenziselwa ukuphatha i-hyponatremia (izinga eliphantsi le-sodium yegazi) ehambelana nokungaphumeleli kwentliziyo, i-cirrhosis, kunye ne-syndrome ye-hormone ye-antidiuretic engafanelekanga (SIADH).I-Otsuka Pharmaceutical inelayisensi ye-tolvaptan phantsi kwegama lorhwebo i-Samsca emva kokuba i-FDA ivume ichiza ngoMeyi ka-2009.